Project Grant R21AI181742
Award Date
11/12/24
Completion Date
10/31/26
Dollars Obligated
$189K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $190,058 to the University of Massachusetts Medical School (UMass Medical) to investigate the role of the ADAM9 protein in the innate immune response to SARS-CoV-2 infection. The study aims to define ADAM9's impact on the immunopathogenesis of severe COVID-19 and its effect on SARS-CoV-2-induced acute lung injury....
This $563,588 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to study the effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity, and clinical outcomes of COVID-19. The project aims to determine the specific immune defects linked to prolonged SARS-CoV-2 replication and genetic diversity within immunocompromised hosts, such as...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $705,557.00 in funding to Emory University to investigate the coordination of innate and cellular mucosal immunity in SARS-CoV-2 clearance. The research aims to determine the contribution of monocytes in promoting T cell responses and viral control within the respiratory tract, as well as define the effector mechanisms...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $3,144,835.86 to The University of Texas Health Science Center at San Antonio (UTHSCSA) over the period of June 25, 2024 to April 30, 2029. The award will support research to advance the understanding of how the immune factor SAMHD1 regulates cellular deoxynucleotide (dNTP) metabolism, and how this relates to its...
This $197,366 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to advance the scientific understanding of how the human immune system naturally restricts a specific subset of HIV, known as X4-tropic virus. The grant recipient, The Washington University, will conduct research to: 1) characterize the molecular mechanisms driving the immune system's restriction of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $148,824 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Research Foundation of the City University of New York (RFCUNY). The goal of this 5-year study is to understand the clinical and social factors impacting HIV and COVID-19 outcomes among people with HIV (PWH), and to characterize how the COVID-19 pandemic, including post-acute sequelae of SARS-CoV-2 infection (PASC), may...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $318,085 to support research on the role of cell, antigen, and antibody in controlling virus infection through Fc-dependent mechanisms. The research aims to understand the molecular determinants that govern how natural killer (NK) cells control virus dissemination through antibody-dependent cellular...
This Project Grant award of $3,298,223.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the molecular mechanisms by which the SARS-CoV-2 nonstructural protein 1 (NSP1) inhibits host mRNA nuclear export and its impact on viral replication and pathogenesis. The research involves a collaborative effort between Vanderbilt University, The University of Texas...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $240,516 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The University of Kentucky Research Foundation. The grant supports research to understand the mechanism of SARS-CoV-2 viral entry by applying single-molecule approaches. The proposed work aims to measure the binding dynamics of the SARS-CoV-2 spike protein and ACE2 receptor, study the detachment kinetics and...
This $640,221 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to define the origin, residence, and longevity of mucosal plasma cells in the upper respiratory tract. The overarching goal is to improve understanding of how antibody-secreting plasma cells establish tissue-specific immunity in the olfactory mucosa, which is critical for protecting against...